CD14 and lung cancer: Importantly, immune cell infiltrates of resected tumors from patients with MPR contained fewer CD16+ neutrophil granulocytes, CD14+ monocytes and CD4+CD25+ regulatory T cells compared with resected lung cancers without MPR (Fig. 3b and Extended Data Fig. 2b).